monitoring a patient on natalizumab for jc virus
Published 10 years ago • 586 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
2:03
risk of pml in patients taking natalizumab
-
8:18
risk analysis of natalizumab in progressive multifocal leukoencephalopathy
-
1:50
a pml risk genetic test to identify at-risk patients on natalizumab
-
2:01
mri imaging of a pml infection
-
9:21
what you need to know about natalizumab (tysabri®)
-
42:10
dr paul molyneux - managing pml risk in patients treated with natalizumab.
-
2:14
safely switching from natalizumab to ocrelizumab in patients with ms at risk of pml
-
5:01
ben turner part 1- nataluzimab (tysabri), pml and jc virus
-
10:41
multiple sclerosis vlog: decoding the jc virus antibody test
-
4:03
extending natalizumab's use without increasing risk to patients
-
6:16
tysabri: pml risk thought experiment
-
4:59
a murine model of jc virus infection
-
37:00
professor david clifford - 'pml and multiple sclerosis'
-
28:35
update on pml
-
7:35
keeping tabs on the jc virus
-
21:01
tysabri pml risk & extended interval dosing
-
14:56
progressive multifocal leukoencephalopathy (pml)
-
3:05
ben turner part 3 - the pathophysiology of jc virus, pml and natiluzimab (tysabri)
-
1:01
pml and natalizumab, progressive multifocal leukoencephalopathy, neurology, multiple sclerosis